Guidance for fluorescence in situ hybridization testing in hematologic disorders

Journal of Molecular Diagnostics

Volumn 9, Issue 2, 2007, Pages 134-143

  Wolff, Daynna J ^a,i   Bagg, Adam ^b   Cooley, Linda D ^c   Dewald, Gordon W ^d   Hirsch, Betsy A ^f   Jacky, Peter B ^e   Rao, Kathleen W ^g   Rao, P Nagesh ^h  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f Northwest Permanente ^*  (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Association for Molecular Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BREAKPOINT CLUSTER REGION PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN ABL1; REAGENT; RETINOIC ACID; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HEALTH CARE POLICY; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; INTERPHASE; LABORATORY TEST; METAPHASE; MOLECULAR MECHANICS; NOMENCLATURE; PATIENT CARE; POLYMERASE CHAIN REACTION; PROMYELOCYTIC LEUKEMIA; RELIABILITY; VALIDATION PROCESS; CELL NUCLEUS; CHROMOSOME BANDING PATTERN; GENETIC SCREENING; METABOLISM; MOLECULAR PROBE;

CELL NUCLEUS; CHROMOSOME BANDING; GENETIC SCREENING; HEMATOLOGIC DISEASES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MOLECULAR PROBES;

EID: 34247894060     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2007.060128     Document Type: Article

References (28)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2001
2. Dewald G, Stallard R, Alsaadi A, Arnold S, Blough R, Ceperich TM, Rafael Elejalde B, Fink J, Higgins JV, Higgins RR, Hoeltge GA, Hsu WT, Johnson EB, Kronberger D, McCorquodale DJ, Meisner LF, Micale MA, Oseth L, Payne JS, Schwartz S, Sheldon S, Sophian A, Storto P, Van Tuinen P, Wenger GD, Wiktor A, Willis LA, Yung JF, Zenger-Hain J: A multicenter investigation with D-FISH BCR/ABL1 probes. Cancer Genet Cytogenet 2000, 116:97-104
3. Ferrant A, Labopin M, Frassoni F, Prentice HG, Cahn JY, Blaise D, Reiffers J, Visani G, Sanz MA, Boogaerts MA, Lowenberg B, Gorin NC: Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood 1997, 90:2931-2938
4. Schad CR, Hanson CA, Paietta E, Casper J, Jalal SM, Dewald GW: Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia. Mayo Clin Proc 1994, 69:1047-1053
5. Döhner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P: Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000, 343:1910-1916
6. Shanafelt TD, Geyer SM, Kay NE: Prognosis at diagnosis: integrating molecular, biologic, insights into clinical practice for patients with CLL. Blood 2004, 103:1202-1210
7. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel L, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch HR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD, Stewart AK, Avet-Loiseau H: Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004, 64:1546-1558
8. Test and Technology Transfer Committee, American College of Medical Genetics: Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Test and Technology Transfer Committee. Genet Med 2000, 2:356-361
9. Dewald G, Stallard R, AI Saadi A, Arnold S, Bader PI, Blough R, Chen H, Elejalde BR, Harris C J, Higgins RR, Hoeltge GA, Hsu WT, Kubic V, McCorquodale DJ, Micale MA, Moore JW, Phillips RM, Scheib-Wixted S, Schwartz S, Siembieda S, Strole K, VanTuinen P, Vance GH, Wiktor A, Wise L, Yung JF, Zenger-Hain J, Zinsmeister A: A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes. Am J Med Genet 1998, 76:318-326
10. Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, Fink SR, Stockero KJ, Majorowicz JR, Dewald GW: Preclinical validation of FISH assays for clinical practice. Genet Med 2006, 8:16-23
11. Stupca PJ, Meyer RG, Dewald GW: Using controls for molecular cytogenetic testing in clinical practice. J Assoc Genet Technol 2005, 31:4-8
12. Mrózek M, Heerema NA, Bloomfield CD: Cytogenetics in acute leukemia. Blood Rev 2004, 18:115-136
13. Shaffer LG, Tommerup N (Eds): ISCN 2005: An International System for Human Cytogenetic Nomenclature. S. Karger, Basel, 2005
14. Tefferi A, Dewald GW, Litzow ML, Cortes J, Mauro MJ, Talpaz M, Kantarjian HM: Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment. Mayo Clin Proc 2005, 80:390-402
15. Ravandi F, Kadkol SS, Ridgeway J, Bruno A, Dodge C, Lindgren V: Molecular identification of CBFbeta-MYH11 fusion transcripts in an AML M4Eo patient in the absence of inv16 or other abnormality by cytogenetic and FISH analyses-a rare occurrence. Leukemia 2003, 17:1907-1910
16. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck SL, Thibodeau SN, Jalal SM: The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 1993, 71:7-14
17. Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM, Spurbeck JL, Silver RT: Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 1998, 91:3357-3365
18. Raynaud SD, Dastugue N, Zoccola D, Shurtleff SA, Mathew S, Raimondi SC: Cytogenetic abnormalities associated with the t(12;21): A collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia. Leukemia 1999, 13:1325-1330
19. Ferrando AA, Look AT: Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol 2000, 37:381-395
20. Jabber Al-Obaidi MS, Martineau M, Bennett CF, Franklin IM, Goldstone AH, Harewood L, Jalali GR, Prentice HG, Richards SM, Roberts K, Harrison CJ; Medical Research Council Adult Leukaemia Working Party: ETV6/AML1 fusion by FISH in adult lymphoblastic leukemia. Leukemia 2002, 16:669-674
21. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larsyn RA, LeBeau MM, Diaz MO, Rowley JD: Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993, 329:909-914
22. Broeker PL, Super HG, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S, Zeleznik-Le N, Rowley JD: Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 1996, 87:1912-22
23. Pui CH, Relling MV: Topoisomerase 2 inhibitor-related acute myeloid leukemia. Br J Haematol 2000, 109:13-23
24. Pui CH, Kane JR, Crist WM: Biology and treatment of infant leukemias. Leukemia 1995, 9:762-769
25. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa III R, Patel Y, Harden A, Rubinelli P, Smith SD, Le Beau M, Rowley JD, Diaz MO: Identification of a gene MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 1991, 88:10735-10739
26. Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W, Loffler H, Hossfeld D, Heil G, Handt S, Heel A, Diedrich H, Fischer K, Weiss A, Volkers B, Aydemir U, Fonatsch C, Gokbuget N, Thiel E, Hoelzer D: Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood 1998, 92:1898-1909
27. Kolomietz E, AI Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, Squire JA: Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001, 97:3581-3588
28. König M, Reichel M, Marschalek R, Haas CA, Strehl S: A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukemias. Br J Haematol 2002, 116:758-764